Sale!

TAB2 Gene Congenital heart defects multiple types Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The TAB2 gene plays a crucial role in the development of the heart during the fetal stage. Mutations in this gene can lead to multiple types of congenital heart defects, which are structural problems with the heart present from birth. These defects can vary widely in severity, from minor issues that may resolve on their own to serious conditions that require immediate medical intervention.

DNA Labs UAE offers a genetic test specifically designed to identify mutations in the TAB2 gene. This test is crucial for early detection of potential congenital heart defects, allowing for prompt medical intervention and management of the condition. The test involves analyzing a sample of the patient’s DNA to look for specific mutations in the TAB2 gene that are known to be associated with congenital heart defects.

The cost of the TAB2 gene congenital heart defects multiple types genetic test at DNA Labs UAE is 4400 AED. The test is conducted in a state-of-the-art laboratory by experienced geneticists and technicians. Results from the test can provide valuable information for families and healthcare providers, guiding decisions about treatment and care for individuals who may be at risk for these heart defects. Early detection through genetic testing can significantly improve outcomes for those affected by congenital heart defects linked to TAB2 gene mutations.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

TAB2 Gene Congenital Heart Defects Multiple Types Genetic Test

Welcome to DNA Labs UAE, where we offer the TAB2 Gene Congenital Heart Defects Multiple Types Genetic Test. This comprehensive genetic test can provide valuable insights into the diagnosis and management of congenital heart defects.

Test Details

The TAB2 gene plays a crucial role in the development of various organs and tissues, including the heart. Mutations in this gene have been linked to the development of congenital heart defects, which are structural abnormalities present at birth. Our NGS (Next-Generation Sequencing) technology allows for the analysis of the TAB2 gene’s DNA sequence, identifying any potential mutations or variants that may contribute to the development of congenital heart defects.

NGS genetic testing enables the simultaneous analysis of multiple genes, providing a comprehensive assessment of an individual’s genetic makeup. By identifying TAB2 gene mutations, this test can aid in the diagnosis of congenital heart defects and provide valuable information for treatment and management strategies. Additionally, it can assist in genetic counseling, helping determine the risk of passing on the condition to future generations.

It is important to note that congenital heart defects can be caused by a combination of genetic and environmental factors, and not all cases can be attributed to mutations in the TAB2 gene. Therefore, a negative genetic test result does not rule out the possibility of a genetic component to the condition. Genetic testing may not be necessary or recommended for all individuals with congenital heart defects, as other diagnostic methods may reveal the underlying cause. Our healthcare professionals can provide guidance on the appropriateness and utility of genetic testing for each specific case.

Test Components and Price

The TAB2 Gene Congenital Heart Defects Multiple Types Genetic Test is priced at 4400.0 AED. The test can be conducted using either blood, extracted DNA, or one drop of blood on an FTA card as a sample condition.

Report Delivery and Method

After conducting the test, the report will be delivered within 3 to 4 weeks. The method used for this genetic test is NGS technology, ensuring accurate and reliable results.

Test Type and Doctor

The TAB2 Gene Congenital Heart Defects Multiple Types Genetic Test falls under the category of Cardiovascular Pneumology Disorders. It is conducted by our experienced Cardiologist, who specializes in genetic testing for heart-related conditions.

Test Department and Pre-Test Information

This genetic test is conducted by our Genetics department. Before undergoing the TAB2 Gene Congenital Heart Defects Multiple Types NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by TAB2 Gene Congenital Heart Defects Multiple Types NGS Genetic DNA Test gene TAB2.

In conclusion, the TAB2 Gene Congenital Heart Defects Multiple Types Genetic Test offered by DNA Labs UAE is a comprehensive and reliable method for diagnosing and managing congenital heart defects. It can provide valuable insights into an individual’s genetic makeup and help determine the risk of passing on the condition to future generations. Our experienced Cardiologist and Genetics department are here to guide you through the testing process and provide personalized recommendations based on your specific case.

Test Name TAB2 Gene Congenital heart defects multiple types Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for TAB2 Gene Congenital heart defects multiple types NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TAB2 Gene Congenital heart defects multiple types NGS Genetic DNA Test gene TAB2
Test Details

The TAB2 gene is involved in the development of various organs and tissues, including the heart. Mutations in this gene have been associated with the development of congenital heart defects, which are structural abnormalities of the heart that are present at birth.

NGS (Next-Generation Sequencing) genetic testing can be used to analyze the DNA sequence of the TAB2 gene and identify any potential mutations or variants that may be contributing to the development of congenital heart defects. This type of genetic testing allows for the simultaneous analysis of multiple genes, providing a comprehensive assessment of an individual’s genetic makeup.

NGS genetic testing for TAB2 gene mutations can help in the diagnosis of congenital heart defects and provide valuable information for treatment and management strategies. It can also be used for genetic counseling purposes, helping to determine the risk of passing on the condition to future generations.

It is important to note that congenital heart defects are often caused by a combination of genetic and environmental factors, and not all cases can be attributed to mutations in the TAB2 gene. Therefore, a negative genetic test result does not rule out the possibility of a genetic component to the condition. Additionally, genetic testing may not be necessary or recommended for all individuals with congenital heart defects, as the underlying cause may be apparent through other diagnostic methods. A healthcare professional can provide guidance on the appropriateness and utility of genetic testing in each specific case.